Policy & Regulation
23 February 2024 - Pharmaceutical company Janssen, a subsidiary of Johnson & Johnson (NYSE:JNJ), announced on Friday that it has received a positive opinion from the Committee for Medicinal Produc...
23 February 2024 - US biotechnology company Biogen Inc (Nasdaq:BIIB) revealed on Friday that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopte...
23 February 2024 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) and US-based biotechnology company Regeneron Pharmaceuticals Inc (Nasdaq:REGN) announced on Friday that the U...
23 February 2024 - Iron deficiency and nephrology specialist CSL Vifor, part of Australian biotechnology company CSL Limited (ASX:CSL), and biopharmaceutical company Travere Therapeutics Inc (NASDAQ:T...
23 February 2024 - TC BioPharm (Holdings) PLC (TCBP) (NASDAQ: TCBP) a UK-based clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other ind...
23 February 2024 - Elevation Oncology, Inc. (Nasdaq: ELEV), a US-based innovative oncology company, announced on Thursday that it has expanded its ongoing Phase one clinical trial of EO-3021 outside t...